Fideuram - Intesa Sanpaolo Private Banking’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.49M Sell
61,715
-596,166
-91% -$15.6M 0.04% 255
2026
Q1
$18.5M Buy
657,881
+580,924
+755% +$15.5M 0.65% 33
2025
Q4
$1.92M Buy
+76,957
New +$1.94M 0.07% 225

Other funds holding PFE

Fideuram - Intesa Sanpaolo Private Banking's PFE Position: Q2 2026 in Review

Fideuram - Intesa Sanpaolo Private Banking reduced its Pfizer (PFE) stake by 91% in Q2 2026, selling an estimated $15.6M and leaving 61,715 shares worth $1.49M. The position accounts for 0.04% of the portfolio, ranked #255.

Fideuram - Intesa Sanpaolo Private Banking first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $18.5M in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Fideuram - Intesa Sanpaolo Private Banking held 61,715 shares of Pfizer worth $1.49M as of Q2 2026.
  • Fideuram - Intesa Sanpaolo Private Banking sold 596,166 Pfizer shares in Q2 2026, an estimated $15.6M.
  • Pfizer made up 0.04% of Fideuram - Intesa Sanpaolo Private Banking's portfolio in Q2 2026, its #255 holding.
  • Fideuram - Intesa Sanpaolo Private Banking first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Fideuram - Intesa Sanpaolo Private Banking's Pfizer position peaked at $18.5M in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Fideuram - Intesa Sanpaolo Private Banking's 13F filing for Q2 2026, filed 23 Jul 2026.